Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMST01020013 CE(20:3) cPLA2i 1.0 BCD110605C28 17.6 pmol/sample
LMST01020013 CE(20:3) cPLA2i 1.0 BCD110605C30 3.95 pmol/sample
LMST01020013 CE(20:3) cPLA2i 1.0 BCD110605C29 6.17 pmol/sample
LMST01020013 CE(20:3) cPLA2i 20.0 BCD110605C64 8.55 pmol/sample
LMST01020013 CE(20:3) cPLA2i 20.0 BCD110605C66 2.91 pmol/sample
LMST01020013 CE(20:3) cPLA2i 20.0 BCD110605C65 5.87 pmol/sample
LMST01020013 CE(20:3) PLDi 1.0 BCD110605C16 15.3 pmol/sample
LMST01020013 CE(20:3) PLDi 1.0 BCD110605C17 6.64 pmol/sample
LMST01020013 CE(20:3) PLDi 1.0 BCD110605C18 3.57 pmol/sample
LMST01020013 CE(20:3) PLDi 20.0 BCD110605C54 3.56 pmol/sample
LMST01020013 CE(20:3) PLDi 20.0 BCD110605C52 6.01 pmol/sample
LMST01020013 CE(20:3) PLDi 20.0 BCD110605C53 3.23 pmol/sample
LMST01020013 CE(20:3) KDO+cPLA2i 1.0 BCD110605C32 4.91 pmol/sample
LMST01020013 CE(20:3) KDO+cPLA2i 1.0 BCD110605C31 10.1 pmol/sample
LMST01020013 CE(20:3) KDO+cPLA2i 1.0 BCD110605C33 4.27 pmol/sample
LMST01020013 CE(20:3) KDO+cPLA2i 20.0 BCD110605C68 4.8 pmol/sample
LMST01020013 CE(20:3) KDO+cPLA2i 20.0 BCD110605C69 4.36 pmol/sample
LMST01020013 CE(20:3) KDO+cPLA2i 20.0 BCD110605C67 10.5 pmol/sample
LMST01020013 CE(20:3) KDO+PLDi 1.0 BCD110605C19 9.28 pmol/sample
LMST01020013 CE(20:3) KDO+PLDi 1.0 BCD110605C20 3.69 pmol/sample
LMST01020013 CE(20:3) KDO+PLDi 1.0 BCD110605C21 3.39 pmol/sample
LMST01020013 CE(20:3) KDO+PLDi 20.0 BCD110605C56 2.6 pmol/sample
LMST01020013 CE(20:3) KDO+PLDi 20.0 BCD110605C57 2.87 pmol/sample
LMST01020013 CE(20:3) KDO+PLDi 20.0 BCD110605C55 7.66 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+cPLA2i 1.0 BCD110605C37 12.9 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+cPLA2i 1.0 BCD110605C38 3.75 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+cPLA2i 1.0 BCD110605C39 4.18 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+cPLA2i 20.0 BCD110605C74 9.92 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+cPLA2i 20.0 BCD110605C75 3.48 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+cPLA2i 20.0 BCD110605C73 14.7 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+PLDi 1.0 BCD110605C25 8.85 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+PLDi 1.0 BCD110605C27 3.42 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+PLDi 1.0 BCD110605C26 3.62 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+PLDi 20.0 BCD110605C61 7.94 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+PLDi 20.0 BCD110605C62 3.26 pmol/sample
LMST01020013 CE(20:3) KDO+ATP+PLDi 20.0 BCD110605C63 4.89 pmol/sample
LMST01020013 CE(20:3) KDO + ATP 1.0 BCD110605C15 3.68 pmol/sample
LMST01020013 CE(20:3) KDO + ATP 1.0 BCD110605C14 6.44 pmol/sample
LMST01020013 CE(20:3) KDO + ATP 1.0 BCD110605C13 16.3 pmol/sample
LMST01020013 CE(20:3) KDO + ATP 20.0 BCD110605C49 10.7 pmol/sample
LMST01020013 CE(20:3) KDO + ATP 20.0 BCD110605C50 3.57 pmol/sample
LMST01020013 CE(20:3) KDO + ATP 20.0 BCD110605C51 4.56 pmol/sample
LMST01020013 CE(20:3) KDO 1.0 BCD110605C08 3.84 pmol/sample
LMST01020013 CE(20:3) KDO 1.0 BCD110605C07 11.9 pmol/sample
LMST01020013 CE(20:3) KDO 1.0 BCD110605C09 3.91 pmol/sample
LMST01020013 CE(20:3) KDO 20.0 BCD110605C45 3.7 pmol/sample
LMST01020013 CE(20:3) KDO 20.0 BCD110605C44 3.51 pmol/sample
LMST01020013 CE(20:3) KDO 20.0 BCD110605C43 4.46 pmol/sample
LMST01020013 CE(20:3) C 0.0 BCD110605C03 8.42 pmol/sample
LMST01020013 CE(20:3) C 0.0 BCD110605C01 25.1 pmol/sample